Interpace Biosciences Inc (STU:PF42)
€ 2.32 -0.14 (-5.69%) Market Cap: 11.03 Mil Enterprise Value: 15.96 Mil PE Ratio: 2.40 PB Ratio: 0 GF Score: 39/100

Q4 2019 Interpace Biosciences Inc Earnings Call Transcript

Apr 22, 2020 / 09:00PM GMT
Release Date Price: €5.7 (+9.62%)
Operator

Greetings. And welcome to the Interpace Biosciences financial and business results conference call. (Operator Instructions) As a reminder, this conference is being recorded.

During this call, the company will make forward-looking statements. We caution you that any statement that is not a statement of historical fact is a forward-looking statement. This includes remarks about the company's financial projections, expectations, plans, beliefs and prospects. These statements are based on judgment and analysis as of the date of the conference call and are subject to numerous important risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties associated with the forward-looking statements made in this call -- conference call are described in the safe harbor statement in today's earnings release as well as Interpace Biosciences public periodic filings, including the discussion in the Risk Factors section in our Form 10-K filed with the SEC on April 22, 2020, which includes discussions in the section

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot